NASDAQ : APYX

Apyx Medical Corporation

$3.86 USD

-$0.03 (-0.77%)

Volume
62.19K
Average Volume
161.96K
Market Capitalization
$162.55M
P/E Ratio
-17.34
Dividend Yield
0.00%
Price Target
$6.50
Year High
$5.08
Year Low
$1.59
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$5.80
Company Overview

NASDAQ

Charles D. Goodwin

Medical - Specialties

Healthcare

APYX

205

US

USD

727 384 2323

03837C106

0000719135

Liquidity Metrics

3.08

5.80

4.79

3.30

0.00

Sales & Valuation

$52.84M

2.91

12.68

-18.08

-0.21

Profitability

-$0.27

-$11.21M

-16.40%

-15.58%

-90.62%

-14.55%

P/E Metrics

-17.34

-0.15

-0.15

Analyst Price Target & Rating

$6.50

$7.00

$6.00

Strong Sell

1/5

9 Analysts

-40.62%

Financial Health Scores

1.53

3/9

$45.35M

$63.02M

$49.94M

-$3.13M

Key Metrics (TTM)

$171.36M

3.07

-70.14

5.80

-90.62%

-7.97%

-5.59%

-5.51%

150 days

Company Executives
Name Title
Matthew C. Hill Chief Financial Officer, Treasurer & Secretary
Shawn D. Roman Chief Operating Officer
Dolores Catania Chief of Confidence
Charles D. Goodwin President, Chief Executive Officer & Director
Moshe Citronowicz Senior Vice President
Poll Results

No votes yet today — be the first to share your view!

About Apyx Medical Corporation (NASDAQ:APYX) Stock

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generat ... ors and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

2026-07-28 08:00:00

CLEARWATER, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that management will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA.

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

2026-07-23 08:00:00

CLEARWATER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that its financial results for the second quarter of fiscal year 2026 will be released after markets close on Thursday, August 6th.

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

2026-05-27 09:51:00

CLEARWATER, Fla., May 27, 2026 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), will return to Miami Swim Week with its Body by Apyx showcase, an immersive runway experience featuring real patient transformations.

New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®

2026-05-21 08:00:00

Published data demonstrates visible reduction in dimpling and progressive tissue remodeling through a single-session approach Published data demonstrates visible reduction in dimpling and progressive tissue remodeling through a single-session approach

Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction

2026-05-14 08:00:00

CLEARWATER, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the publication of a new retrospective investigator-initiated study in Plastic and Reconstructive Surgery - Global Open 1.

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

2026-05-11 08:00:00

Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

2026-05-07 19:11:17

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

2026-05-07 09:51:05

Apyx Medical (APYX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.1 per share a year ago.

Frequently Asked Questions

What is the current Apyx Medical Corporation (APYX) stock price?

Apyx Medical Corporation(NASDAQ:APYX) stock price is $3.86 in the last trading session. During the trading session, APYX stock reached the peak price of $5.08 while $1.59 was the lowest point it dropped to. The percentage change in APYX stock occurred in the recent session was --0.77% while the dollar amount for the price change in APYX stock was -$0.03.

APYX's industry and sector of operation?

The NASDAQ listed APYX is part of Medical - Specialties industry that operates in the broader Healthcare sector.

Who are the executives of APYX?

Matthew C. Hill | Chief Financial Officer, Treasurer & Secretary
Shawn D. Roman | Chief Operating Officer
Dolores Catania | Chief of Confidence
Charles D. Goodwin | President, Chief Executive Officer & Director
Moshe Citronowicz | Senior Vice President

How many employees does APYX have?

Number of APYX employees currently stands at 205. APYX operates from 5115 Ulmerton Road, Clearwater, FL 33760-4004, US.

Link for APYX official website?

Official Website of APYX is: https://apyxmedical.com

How do I contact APYX?

APYX could be contacted at phone #727 384 2323 and can also be accessed through its website. APYX operates from 5115 Ulmerton Road, Clearwater, FL 33760-4004, US.

How many shares of APYX are traded daily?

The average number of APYX shares traded daily for last 3 months was 161.96K.

What is the market cap of APYX currently?

The market value of APYX currently stands at $162.55M with its latest stock price at $3.86